Investment in British artificial intelligence reached $9.6bn (£7.2bn) during the first six months of 2026, a rise of 360% on the same period a year earlier. The figures, published by the data intelligence platform Tracxn Technologies, span 69 funding rounds and show a 284% increase on the second half of 2025.
The results confirm the UK as one of the most attractive destinations in the world for AI capital. International and domestic investors alike are committing substantial sums to British founders, and they are doing so at every stage of a company’s development.
Beneath the headline total sits a market gaining real depth. Funding grew at seed, early and late stage, new unicorns emerged from British research, and companies reaching acquisition had raised more capital and spent longer building than their predecessors.
Five companies set the pace
The five most funded companies raised $8.1bn between them, equal to 84% of the half-year total. Isomorphic Labs secured $2.1bn in a Series B round, Nscale closed a $2bn Series C and the autonomous driving company Wayve added $1.2bn through its Series D, giving the three businesses a combined $5.3bn.
Rounds of this size bring benefits that reach well into the wider ecosystem. Each gives its recipient the resources to recruit senior talent, expand computing capacity and compete for international contracts. They also provide a visible benchmark that encourages further investment into British businesses.
Growth at every stage
Momentum was visible across the full maturity curve, from first cheques to late stage expansion. Seed funding reached $1.2bn, early stage rounds totalled $4.6bn and late stage investment came to $3.8bn, with gains recorded at each level.
AI infrastructure attracted the most capital of any sector at $5.4bn, followed by high-performance computing at $3.7bn and life sciences technology at $2.1bn. The weighting towards infrastructure shows investors backing the computing power and underlying systems on which future AI products depend, alongside the applications that reach consumers. The strong showing for life sciences technology builds on the UK’s long record in pharmaceutical and academic research.
A new generation of unicorns
The half produced new unicorns with genuine British credentials. Odyssey, the world model AI startup founded by Oliver Cameron and Jeff Hawke, crossed the $1bn valuation mark after a $310m Series B led by Natural Capital, with Amazon and GV also taking part.
Ineffable Intelligence, led by University College London professor David Silver, reached unicorn status through a record $1.1bn seed round. The raise signals considerable confidence in research emerging from British universities. FluidStack, meanwhile, raised $842m and $830m across two separate Series A rounds, a combined total of more than $1.6bn.
London leads the field
London attracted 98% of all UK AI funding in the period, some $9.4bn, up from a 93% share in the previous six months. Oxford placed second with $103m, ahead of Cambridge at $18.3m, Edinburgh at $16.1m and Milton Keynes at $12m.
The capital’s lead reflects a concentration of talent, research institutions and investment firms that few European cities can match. The presence of Oxford, Cambridge, Edinburgh and Milton Keynes in the rankings gives regional centres a clear base of activity, supported by strong university links, from which further growth can follow.
Investors compete throughout
An increasingly professional investor base stands behind the totals. Y Combinator, Entrepreneur First and 20VC Fund were the most active investors at seed stage. Index Ventures, Octopus Ventures and Google Ventures led early stage activity, while SoftBank Vision Fund, Eclipse and Atomico dominated late stage rounds.
British and global firms now compete for positions in the same companies throughout their development. Founders gain access to capital and specialist expertise at each step, and the market as a whole benefits from a funding chain able to carry a business from its first round to its largest.
A patient and maturing market
Exit activity has remained steady, with six acquisitions completed during the half, the same number as a year earlier. The companies acquired had raised an average of $69.8m before their sale, up from $52m.
The average time from first funding to acquisition lengthened from 6.3 years to 7.9 years. Founders are building for the longer term before accepting offers, a pattern that points to larger and more established businesses coming to market when a sale does take place.
Acting on the momentum
The first half of 2026 leaves British AI in a strong position, with capital flowing at every stage and a pipeline of companies deeper than at any point in the industry’s short history. For investors, activity across seed, early and late stage offers entry points to suit a range of appetites, while infrastructure and life sciences technology present clear areas of focus.
Businesses outside the technology sector have equally practical opportunities. Partnering with British AI companies, piloting their products and building relationships with the most active fund managers all offer early access to capabilities now attracting global investment. Organisations that engage at this stage will be well placed to benefit as today’s growth companies develop into the next generation of market leaders